首页> 外国专利> Artificial blood substitutes - contg. albumin and artificial colloid, pref. of hydroxy ethyl starch

Artificial blood substitutes - contg. albumin and artificial colloid, pref. of hydroxy ethyl starch

机译:人造血替代品-续白蛋白和人工胶体,优选。羟乙基淀粉

摘要

A plasma substitute comprises human albumin and at least one artificial colloid, the concentration of the artificial colloid(s) being at least equal, and preferably superior, to the albumin concentration, the albumin concentration is 10-30 g/litre, and the total colloid concentration, i.e. albumin + artificial colloids, being 40-60 g/litre. Pref. the artificial colloid is preferably a modified gelatine, a dextran, or a hydroxy ethyl starch, esp. one of 200 000 daltons. The albumin concentration is preferably 10-30 g/litre, and the artificial colloid conc. is 50-30 g/litre. USE/ADVANTAGE - Blood replacement during pre-operatory haemodilution to normalise circulating blood volume, or for vascular filling to compensate for blood loss. The new plasma substitute poses less risks than prior art plasma substitutes, even when large volumes are involved, and is more readily accessible.
机译:血浆替代物包含人白蛋白和至少一种人工胶体,一种或多种人工胶体的浓度至少等于,优选地优于白蛋白浓度,白蛋白浓度为10-30 g / L,总和胶体浓度,即白蛋白+人工胶体浓度为40-60 g / L。首选人造胶体优选是改性明胶,右旋糖酐或羟乙基淀粉,特别是。 20万道尔顿之一。白蛋白浓度优选为10-30g /升,并且人造胶体为浓。是50-30克/升。使用/优势-术前血液稀释过程中的血液置换可正常化循环血容量,或用于血管充盈以补偿失血。与现有技术的血浆替代品相比,新的血浆替代品带来的风险较小,即使涉及大体积且更容易获得。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号